CLDN18 and autoimmune gastritis: Immunohistochemical analyses targeting claudin 18 revealed that 18.9% of autoimmune gastritis cases with intestinal metaplasia manifest positive staining, in contrast to 71.4% in those without autoimmune gastritis, indicating the distinct nature of intestinal metaplasia in autoimmune gastritis [36].